Covance Page

Formerly known as Covance Inc., this company is a major Contract Research Organization (CRO) that manages clinical trials and laboratory testing.

Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services: COVANCE

Volunteers can find active clinical trials through the official Labcorp site or ClinicalTrials.gov . 2. Covance (The Medication) Formerly known as Covance Inc

It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain. Key Services: Volunteers can find active clinical trials

This medication is unsafe during pregnancy and can cause serious harm to an unborn baby.

Assisting companies with FDA filings and drug commercialization.

Reduces the risk of in patients with an enlarged heart. Protects kidney function in patients with Type 2 diabetes.

Formerly known as Covance Inc., this company is a major Contract Research Organization (CRO) that manages clinical trials and laboratory testing.

Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services:

Volunteers can find active clinical trials through the official Labcorp site or ClinicalTrials.gov . 2. Covance (The Medication)

It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain.

This medication is unsafe during pregnancy and can cause serious harm to an unborn baby.

Assisting companies with FDA filings and drug commercialization.

Reduces the risk of in patients with an enlarged heart. Protects kidney function in patients with Type 2 diabetes.